MEREO BIOPHARMA Cash on Hand 2024-2024 | MREO
MEREO BIOPHARMA cash on hand from 2024 to 2024. Cash on hand can be defined as cash deposits at financial institutions that can immediately be withdrawn at any time, and investments maturing in one year or less that are highly liquid and therefore regarded as cash equivalents and reported with or near cash line items.
| MEREO BIOPHARMA Annual Cash on Hand (Millions of US $) |
|
|---|---|
| 2023 | $57 |
| 2022 | $68 |
| 2021 | $130 |
| 2020 | $30 |
| 2019 | $21 |
| 2018 | $37 |
| MEREO BIOPHARMA Quarterly Cash on Hand (Millions of US $) |
|
|---|---|
| 2024-03-31 | $49 |
| 2023-12-31 | $57 |
| 2023-03-31 | |
